References
- Cancer in Norway 2017 – cancer incidence, mortality and prevalence in Norway. Cancer registry of Norway, 2018. [cited 2019 Jun 21]. Available from: https://www.kreftregisteret.no/Generelt/Rapporter/Cancer-in-Norway/cancer-in-norway-2017/
- Van Leeuwen FE, Ng AK. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. Hematol Am Soc Hematol Educ Program. 2016;2016:323–330.
- Majhail NS, Ness KK, Burns LJ, et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant. 2007;13:1153–1159.
- Bersvendsen HS, Haugnes HS, Fagerli UM, et al. Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes. Acta Oncol 2019;58:690–699.
- Smeland KB, Kiserud CE, Lauritzsen GF, et al. High-dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008. Tidsskriftet. 2013;133:1704–1709.
- Gianinazzi ME, Essig S, Rueegg CS, et al. Information provision and information needs in adult survivors of childhood cancer. Pediatr Blood Cancer. 2014;61:312–318.
- Vetsch J, Fardell JE, Wakefield CE, et al. “Forewarned and forearmed”: long-term childhood cancer survivors' and parents' information needs and implications for survivorship models of care. Patient Educ Couns. 2017;100:355–363.
- DeRouen MC, Smith AW, Tao L, et al. Cancer-related information needs and cancer's impact on control over life influence health-related quality of life among adolescents and young adults with cancer. Psychooncology. 2015;24:1104–1115.
- Lie HC, Loge JH, Fossa SD, et al. Providing information about late effects after childhood cancer: lymphoma survivors' preferences for what, how and when. Patient Educ Couns. 2015;98:604–611.
- Hess SL, Johannsdottir IM, Hamre H, et al. Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects. Acta Oncol. 2011;50:653–659.
- Lindell RB, Koh SJ, Alvarez JM, et al. Knowledge of diagnosis, treatment history, and risk of late effects among childhood cancer survivors and parents: the impact of a survivorship clinic. Pediatr Blood Cancer. 2015;62:1444–1451.
- Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309:2371–2381.
- Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2328–2338.
- Christen S, Weishaupt E, Vetsch J, et al. Perceived information provision and information needs in adolescent and young adult cancer survivors. Eur J Cancer Care. 2019;28:e12892.
- Kent EE, Arora NK, Rowland JH, et al. Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Patient Educ Couns. 2012;89:345–352.
- Murbraech K, Smeland KB, Holte H, et al. Heart failure and asymptomatic left ventricular systolic dysfunction in lymphoma survivors treated with autologous stem-cell transplantation: a national cross-sectional study. J Clin Oncol. 2015;33:2683–2691.
- National manual with guidelines for the diagnosis, treatment and follow-up of malignant lymphomas, IS-nummer 2747 [Internet]. The Norwegian Health Directory [cited 2019 Jan 01]. Available from: https://www.helsedirektoratet.no/pakkeforlop/lymfomer
- Ware JE, Kosinski M, Gandek B. SF-36 health survey: manual & interpretation guide. 2nd ed. Boston (MA): Lincoln (RI): Health Assessment Lab; QualityMetric; 2000.
- Ware JE, Jr., Gandek B, Kosinski M, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. J Clin Epidemiol. 1998;51:1167–1170.
- Gandek B, Sinclair SJ, Kosinski M, et al. Psychometric evaluation of the SF-36 health survey in medicare managed care. Health Care Financ Rev. 2004;25:5–25.
- Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147–153.
- Loge JH, Ekeberg O, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res. 1998;45:53–65.
- Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69–77.
- Krokstad S, Langhammer A, Hveem K, et al. Cohort profile: the HUNT Study, Norway. Int J Epidemiol. 2013;42:968–977.
- World Health Organisation [Internet]. Global recommendation on physical activity for health; 2010. [cited 2019 Jun 21]. Available from: https://www.who.int/dietphysicalactivity/factsheet_adults/en/
- Shapiro CL. Cancer survivorship. N Engl J Med. 2018;379:2438–2450.
- Ross L, Petersen MA, Johnsen AT, et al. Satisfaction with information provided to Danish cancer patients: validation and survey results. Patient Educ Couns. 2013;93:239–247.
- Oktay K, Harvey BE, Loren AW. Fertility preservation in patients with cancer: ASCO clinical practice guideline update summary. J Oncol Pract. 2018;14:381–385.
- Dillon DG, Pizzagalli DA. Mechanisms of memory disruption in depression. Trends Neurosci. 2018;41:137–149.
- Husson O, Mols F, van de Poll-Franse LV. The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol. 2011;22:761–772.
- Sutradhar R, Agha M, Pole JD, et al. Specialized survivor clinic attendance is associated with decreased rates of emergency department visits in adult survivors of childhood cancer. Cancer. 2015;121:4389–4397.
- Til deg som har fått strålebehandling for lymfekreft- viktig informasjon om forebygging om mulige senskader [To the patient who has received radiotherapy for lymphoma – important information on the prevention of late adverse effects]. The Norwegian Health Directory, The Norwegian Lymphoma Group, The Norwegian Cancer Association, editor. 2012. [cited 2019 Jun 21]. Available from: https://www.helsedirektoratet.no/brosjyrer/til-deg-som-har-fatt-stralebehandling-for-lymfekreft
- Bower JE, Bak K, Berger A, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014;32:1840–1850.
- Campbell MK, Tessaro I, Gellin M, et al. Adult cancer survivorship care: experiences from the LIVESTRONG centers of excellence network. J Cancer Surviv. 2011;5:271–282.